• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特定中性粒细胞蛋白血浆浓度在克罗恩病和溃疡性结肠炎诊断中的应用——初步报告

The use of selected neutrophil protein plasma concentrations in the diagnosis of Crohn's disease and ulcerative colitis - a preliminary report.

作者信息

Pawlica-Gosiewska Dorota, Solnica Bogdan, Gawlik Katarzyna, Cibor Dorota, Mach Tomasz, Fedak Danuta, Owczarek Danuta

机构信息

Department of Diagnostics, Chair of Clinical Biochemistry Jagiellonian University Medical College Krakow, Poland.

Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Krakow, Poland.

出版信息

Postepy Hig Med Dosw (Online). 2017 Apr 6;71(0):243-253. doi: 10.5604/01.3001.0010.3810.

DOI:10.5604/01.3001.0010.3810
PMID:28397705
Abstract

BACKGROUND

Difficulties in diagnosis of inflammatory bowel disease (IBD) motivate the search for new diagnostic tools, including laboratory tests. The aim of this study was to evaluate concentrations of the neutrophil (NEU) proteins leukocyte elastase (HLE-α1AT), lactoferrin and calprotectin as potential biomarkers used in the diagnosis and assessment of clinical activity of Crohn's disease (CD) and ulcerative colitis (UC).

MATERIAL/METHODS: The study included 27 patients with CD, 33 patients with UC and 20 healthy controls. Plasma concentrations of calprotectin, lactoferrin and HLE-α1AT were measured using ELISA.

RESULTS

In patients with CD higher concentrations of HLE-α1AT (64.3±43.1 vs. 30.1±7.7 ng/l, P<0.001), calprotectin (151.6±97.8 vs. 69.9±22.1 ng/l, P<0.001) and lactoferrin (243.2±102.0 vs. 129.7±32.7 ng/l, P<0.001) than in the control group were found. In patients with UC higher plasma concentrations of HLE-α1AT (62.0±30.9 vs. 30.1±7.7 ng/l, P<0.001), calprotectin (149.6±72.3 vs. 69.9±22.1 ng/l, P<0.001) and lactoferrin (242.6±107.5 vs 129.7±32.7 ng/l, P<0.001) than in the control group were found. HLE-α1AT/NEU and lactoferrin/NEU ratios in patients with UC were significantly higher compared with patients with CD. Calprotectin (P=0.010) and lactoferrin (P=0.023) levels were higher in patients with the active compared with inactive phase of CD.

CONCLUSIONS

The diagnostic characteristics of plasma granulocyte protein concentrations indicate the usefulness of these tests in the diagnosis of IBD. Higher HLE-α1AT and lactoferrin/NEU ratios in patients with UC than with CD may suggest the usefulness of these ratios in differential diagnostics. Plasma calprotectin and lactoferrin levels may be useful in CD activity assessment.

摘要

背景

炎症性肠病(IBD)的诊断困难促使人们寻找新的诊断工具,包括实验室检测。本研究的目的是评估中性粒细胞(NEU)蛋白白细胞弹性蛋白酶(HLE-α1AT)、乳铁蛋白和钙卫蛋白的浓度,作为用于诊断和评估克罗恩病(CD)和溃疡性结肠炎(UC)临床活动度的潜在生物标志物。

材料/方法:本研究纳入了27例CD患者、33例UC患者和20名健康对照者。采用酶联免疫吸附测定法(ELISA)测量血浆中钙卫蛋白、乳铁蛋白和HLE-α1AT的浓度。

结果

发现CD患者的HLE-α1AT浓度(64.3±43.1 vs. 30.1±7.7 ng/l,P<0.001)、钙卫蛋白浓度(151.6±97.8 vs. 69.9±22.1 ng/l,P<0.001)和乳铁蛋白浓度(243.2±102.0 vs. 129.7±32.7 ng/l,P<0.001)均高于对照组。UC患者的血浆HLE-α1AT浓度(62.0±30.9 vs. 30.1±7.7 ng/l,P<0.001)、钙卫蛋白浓度(149.6±72.3 vs. 69.9±22.1 ng/l,P<0.001)和乳铁蛋白浓度(242.6±107.5 vs 129.7±32.7 ng/l,P<0.001)也高于对照组。UC患者的HLE-α1AT/NEU和乳铁蛋白/NEU比值显著高于CD患者。CD活动期患者与非活动期患者相比,钙卫蛋白水平(P=0.010)和乳铁蛋白水平(P=0.023)更高。

结论

血浆粒细胞蛋白浓度的诊断特征表明这些检测在IBD诊断中的有用性。UC患者的HLE-α1AT和乳铁蛋白/NEU比值高于CD患者,这可能提示这些比值在鉴别诊断中的有用性。血浆钙卫蛋白和乳铁蛋白水平可能有助于评估CD的活动度。

相似文献

1
The use of selected neutrophil protein plasma concentrations in the diagnosis of Crohn's disease and ulcerative colitis - a preliminary report.特定中性粒细胞蛋白血浆浓度在克罗恩病和溃疡性结肠炎诊断中的应用——初步报告
Postepy Hig Med Dosw (Online). 2017 Apr 6;71(0):243-253. doi: 10.5604/01.3001.0010.3810.
2
Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.炎症性肠病患者血清钙卫蛋白水平的评估。
Kurume Med J. 2021 Dec 15;66(4):209-215. doi: 10.2739/kurumemedj.MS664009. Epub 2021 Oct 25.
3
Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.粪便钙卫蛋白和乳铁蛋白用于预测炎症性肠病复发
Inflamm Bowel Dis. 2009 Aug;15(8):1190-8. doi: 10.1002/ibd.20933.
4
[Application of chosen granulocyte markers in diagnostics of Leśniowski-Crohn's disease and ulcerative colitis--preliminary research].[所选粒细胞标志物在莱什尼奥夫斯基 - 克罗恩病和溃疡性结肠炎诊断中的应用——初步研究]
Przegl Lek. 2010;67(2):114-8.
5
Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization.炎症性肠病中钙卫蛋白的检测:粪便和血清水平及免疫组化定位。
Int J Mol Med. 2018 Jan;41(1):107-118. doi: 10.3892/ijmm.2017.3244. Epub 2017 Nov 7.
6
Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis.溃疡性结肠炎患者直肠透析液和粪便中中性粒细胞明胶酶相关脂质运载蛋白、白细胞介素-8及肿瘤坏死因子-α的浓度
Am J Gastroenterol. 1999 Oct;94(10):2923-8. doi: 10.1111/j.1572-0241.1999.01439.x.
7
Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.粪便中人类中性粒细胞肽水平与溃疡性结肠炎的肠道炎症相关。
Digestion. 2016;93(4):300-8. doi: 10.1159/000446210. Epub 2016 May 26.
8
Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.粪便钙卫蛋白是炎症性肠病内镜下病变的替代标志物。
Inflamm Bowel Dis. 2012 Dec;18(12):2218-24. doi: 10.1002/ibd.22917. Epub 2012 Feb 16.
9
[Significance of serum calprotectin in assessing inflammatory bowel disease activity].[血清钙卫蛋白在评估炎症性肠病活动度中的意义]
Zhonghua Yi Xue Za Zhi. 2017 Oct 17;97(38):3001-3004. doi: 10.3760/cma.j.issn.0376-2491.2017.38.011.
10
Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.炎症性肠病中肠道炎症评估的非侵入性标志物:粪便乳铁蛋白、钙卫蛋白、PMN弹性蛋白酶、CRP及临床指标的表现
Am J Gastroenterol. 2008 Jan;103(1):162-9. doi: 10.1111/j.1572-0241.2007.01556.x. Epub 2007 Oct 4.

引用本文的文献

1
Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment Outcomes.预测克罗恩病进展和英夫利昔单抗治疗结果的血清中性粒细胞生物标志物
United European Gastroenterol J. 2025 Mar;13(2):229-239. doi: 10.1002/ueg2.12712. Epub 2024 Dec 8.
2
Preclinical Markers in Inflammatory Bowel Disease. A Nested Case-Control Study.炎症性肠病的临床前标志物。一项巢式病例对照研究。
Crohns Colitis 360. 2021 Oct 19;3(4):otab072. doi: 10.1093/crocol/otab072. eCollection 2021 Oct.